0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Psychobiotics Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-3F18699
Home | Market Reports | Health| Nursing
Global Psychobiotics Market Research Report 2024
BUY CHAPTERS

Global Psychobiotics Market Research Report 2024

Code: QYRE-Auto-3F18699
Report
November 2024
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Psychobiotics Market

The global Psychobiotics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Psychobiotics are a novel class of probiotics that influence brain function and behavior through the gut-brain axis. The gut-brain axis refers to the bidirectional communication between the central nervous system and the gut microbiome, linking cognitive and emotional centers of the brain with intestinal functions. This axis plays a crucial role in influencing mood, cognition, and overall mental health.
North American market for Psychobiotics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Psychobiotics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Psychobiotics include Lallemand Inc, Novonesis (Novozymes A/S), Bened Biomedical, Sabinsa Corporation, DuPont Nutrition & Biosciences, Kerry Group, Bioprox, Chr. Hansen, Mystical Biotech, Synbiotech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Psychobiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psychobiotics.
The Psychobiotics market size, estimations, and forecasts are provided in terms of sales volume (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Psychobiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psychobiotics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Psychobiotics Market Report

Report Metric Details
Report Name Psychobiotics Market
by Type
  • Bifidobacterium Longum
  • Lactobacillus Acidophilus
  • Lactobacillus Casei
  • Other
by Application
  • Depression
  • Stress
  • Anxiety
  • Other
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Lallemand Inc, Novonesis (Novozymes A/S), Bened Biomedical, Sabinsa Corporation, DuPont Nutrition & Biosciences, Kerry Group, Bioprox, Chr. Hansen, Mystical Biotech, Synbiotech, Glac biotech Co., Ltd., Ildong Bioscience Co. Ltd, JuneYao Health (BioGrowing Co., Ltd), Unique Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Psychobiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Psychobiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Psychobiotics Market report?

Ans: The main players in the Psychobiotics Market are Lallemand Inc, Novonesis (Novozymes A/S), Bened Biomedical, Sabinsa Corporation, DuPont Nutrition & Biosciences, Kerry Group, Bioprox, Chr. Hansen, Mystical Biotech, Synbiotech, Glac biotech Co., Ltd., Ildong Bioscience Co. Ltd, JuneYao Health (BioGrowing Co., Ltd), Unique Biotech

What are the Application segmentation covered in the Psychobiotics Market report?

Ans: The Applications covered in the Psychobiotics Market report are Depression, Stress, Anxiety, Other

What are the Type segmentation covered in the Psychobiotics Market report?

Ans: The Types covered in the Psychobiotics Market report are Bifidobacterium Longum, Lactobacillus Acidophilus, Lactobacillus Casei, Other

1 Psychobiotics Market Overview
1.1 Product Definition
1.2 Psychobiotics by Type
1.2.1 Global Psychobiotics Market Value Comparison by Type (2024-2030)
1.2.2 Bifidobacterium Longum
1.2.3 Lactobacillus Acidophilus
1.2.4 Lactobacillus Casei
1.2.5 Other
1.3 Psychobiotics by Application
1.3.1 Global Psychobiotics Market Value by Application (2024-2030)
1.3.2 Depression
1.3.3 Stress
1.3.4 Anxiety
1.3.5 Other
1.4 Global Psychobiotics Market Size Estimates and Forecasts
1.4.1 Global Psychobiotics Revenue 2019-2030
1.4.2 Global Psychobiotics Sales 2019-2030
1.4.3 Global Psychobiotics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Psychobiotics Market Competition by Manufacturers
2.1 Global Psychobiotics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Psychobiotics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Psychobiotics Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Psychobiotics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Psychobiotics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Psychobiotics, Product Type & Application
2.7 Global Key Manufacturers of Psychobiotics, Date of Enter into This Industry
2.8 Global Psychobiotics Market Competitive Situation and Trends
2.8.1 Global Psychobiotics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Psychobiotics Players Market Share by Revenue
2.8.3 Global Psychobiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Psychobiotics Market Scenario by Region
3.1 Global Psychobiotics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Psychobiotics Sales by Region: 2019-2030
3.2.1 Global Psychobiotics Sales by Region: 2019-2024
3.2.2 Global Psychobiotics Sales by Region: 2025-2030
3.3 Global Psychobiotics Revenue by Region: 2019-2030
3.3.1 Global Psychobiotics Revenue by Region: 2019-2024
3.3.2 Global Psychobiotics Revenue by Region: 2025-2030
3.4 North America Psychobiotics Market Facts & Figures by Country
3.4.1 North America Psychobiotics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Psychobiotics Sales by Country (2019-2030)
3.4.3 North America Psychobiotics Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Psychobiotics Market Facts & Figures by Country
3.5.1 Europe Psychobiotics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Psychobiotics Sales by Country (2019-2030)
3.5.3 Europe Psychobiotics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Psychobiotics Market Facts & Figures by Region
3.6.1 Asia Pacific Psychobiotics Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Psychobiotics Sales by Region (2019-2030)
3.6.3 Asia Pacific Psychobiotics Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Psychobiotics Market Facts & Figures by Country
3.7.1 Latin America Psychobiotics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Psychobiotics Sales by Country (2019-2030)
3.7.3 Latin America Psychobiotics Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Psychobiotics Market Facts & Figures by Country
3.8.1 Middle East and Africa Psychobiotics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Psychobiotics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Psychobiotics Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Psychobiotics Sales by Type (2019-2030)
4.1.1 Global Psychobiotics Sales by Type (2019-2024)
4.1.2 Global Psychobiotics Sales by Type (2025-2030)
4.1.3 Global Psychobiotics Sales Market Share by Type (2019-2030)
4.2 Global Psychobiotics Revenue by Type (2019-2030)
4.2.1 Global Psychobiotics Revenue by Type (2019-2024)
4.2.2 Global Psychobiotics Revenue by Type (2025-2030)
4.2.3 Global Psychobiotics Revenue Market Share by Type (2019-2030)
4.3 Global Psychobiotics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Psychobiotics Sales by Application (2019-2030)
5.1.1 Global Psychobiotics Sales by Application (2019-2024)
5.1.2 Global Psychobiotics Sales by Application (2025-2030)
5.1.3 Global Psychobiotics Sales Market Share by Application (2019-2030)
5.2 Global Psychobiotics Revenue by Application (2019-2030)
5.2.1 Global Psychobiotics Revenue by Application (2019-2024)
5.2.2 Global Psychobiotics Revenue by Application (2025-2030)
5.2.3 Global Psychobiotics Revenue Market Share by Application (2019-2030)
5.3 Global Psychobiotics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Lallemand Inc
6.1.1 Lallemand Inc Company Information
6.1.2 Lallemand Inc Description and Business Overview
6.1.3 Lallemand Inc Psychobiotics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Lallemand Inc Psychobiotics Product Portfolio
6.1.5 Lallemand Inc Recent Developments/Updates
6.2 Novonesis (Novozymes A/S)
6.2.1 Novonesis (Novozymes A/S) Company Information
6.2.2 Novonesis (Novozymes A/S) Description and Business Overview
6.2.3 Novonesis (Novozymes A/S) Psychobiotics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novonesis (Novozymes A/S) Psychobiotics Product Portfolio
6.2.5 Novonesis (Novozymes A/S) Recent Developments/Updates
6.3 Bened Biomedical
6.3.1 Bened Biomedical Company Information
6.3.2 Bened Biomedical Description and Business Overview
6.3.3 Bened Biomedical Psychobiotics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bened Biomedical Psychobiotics Product Portfolio
6.3.5 Bened Biomedical Recent Developments/Updates
6.4 Sabinsa Corporation
6.4.1 Sabinsa Corporation Company Information
6.4.2 Sabinsa Corporation Description and Business Overview
6.4.3 Sabinsa Corporation Psychobiotics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sabinsa Corporation Psychobiotics Product Portfolio
6.4.5 Sabinsa Corporation Recent Developments/Updates
6.5 DuPont Nutrition & Biosciences
6.5.1 DuPont Nutrition & Biosciences Company Information
6.5.2 DuPont Nutrition & Biosciences Description and Business Overview
6.5.3 DuPont Nutrition & Biosciences Psychobiotics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 DuPont Nutrition & Biosciences Psychobiotics Product Portfolio
6.5.5 DuPont Nutrition & Biosciences Recent Developments/Updates
6.6 Kerry Group
6.6.1 Kerry Group Company Information
6.6.2 Kerry Group Description and Business Overview
6.6.3 Kerry Group Psychobiotics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kerry Group Psychobiotics Product Portfolio
6.6.5 Kerry Group Recent Developments/Updates
6.7 Bioprox
6.7.1 Bioprox Company Information
6.7.2 Bioprox Description and Business Overview
6.7.3 Bioprox Psychobiotics Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Bioprox Psychobiotics Product Portfolio
6.7.5 Bioprox Recent Developments/Updates
6.8 Chr. Hansen
6.8.1 Chr. Hansen Company Information
6.8.2 Chr. Hansen Description and Business Overview
6.8.3 Chr. Hansen Psychobiotics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Chr. Hansen Psychobiotics Product Portfolio
6.8.5 Chr. Hansen Recent Developments/Updates
6.9 Mystical Biotech
6.9.1 Mystical Biotech Company Information
6.9.2 Mystical Biotech Description and Business Overview
6.9.3 Mystical Biotech Psychobiotics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mystical Biotech Psychobiotics Product Portfolio
6.9.5 Mystical Biotech Recent Developments/Updates
6.10 Synbiotech
6.10.1 Synbiotech Company Information
6.10.2 Synbiotech Description and Business Overview
6.10.3 Synbiotech Psychobiotics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Synbiotech Psychobiotics Product Portfolio
6.10.5 Synbiotech Recent Developments/Updates
6.11 Glac biotech Co., Ltd.
6.11.1 Glac biotech Co., Ltd. Company Information
6.11.2 Glac biotech Co., Ltd. Description and Business Overview
6.11.3 Glac biotech Co., Ltd. Psychobiotics Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Glac biotech Co., Ltd. Psychobiotics Product Portfolio
6.11.5 Glac biotech Co., Ltd. Recent Developments/Updates
6.12 Ildong Bioscience Co. Ltd
6.12.1 Ildong Bioscience Co. Ltd Company Information
6.12.2 Ildong Bioscience Co. Ltd Description and Business Overview
6.12.3 Ildong Bioscience Co. Ltd Psychobiotics Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Ildong Bioscience Co. Ltd Psychobiotics Product Portfolio
6.12.5 Ildong Bioscience Co. Ltd Recent Developments/Updates
6.13 JuneYao Health (BioGrowing Co., Ltd)
6.13.1 JuneYao Health (BioGrowing Co., Ltd) Company Information
6.13.2 JuneYao Health (BioGrowing Co., Ltd) Description and Business Overview
6.13.3 JuneYao Health (BioGrowing Co., Ltd) Psychobiotics Sales, Revenue and Gross Margin (2019-2024)
6.13.4 JuneYao Health (BioGrowing Co., Ltd) Psychobiotics Product Portfolio
6.13.5 JuneYao Health (BioGrowing Co., Ltd) Recent Developments/Updates
6.14 Unique Biotech
6.14.1 Unique Biotech Company Information
6.14.2 Unique Biotech Description and Business Overview
6.14.3 Unique Biotech Psychobiotics Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Unique Biotech Psychobiotics Product Portfolio
6.14.5 Unique Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Psychobiotics Industry Chain Analysis
7.2 Psychobiotics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Psychobiotics Production Mode & Process
7.4 Psychobiotics Sales and Marketing
7.4.1 Psychobiotics Sales Channels
7.4.2 Psychobiotics Distributors
7.5 Psychobiotics Customers
8 Psychobiotics Market Dynamics
8.1 Psychobiotics Industry Trends
8.2 Psychobiotics Market Drivers
8.3 Psychobiotics Market Challenges
8.4 Psychobiotics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Psychobiotics Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Psychobiotics Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Psychobiotics Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Psychobiotics Sales (Ton) of Key Manufacturers (2019-2024)
 Table 5. Global Psychobiotics Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Psychobiotics Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Psychobiotics Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Psychobiotics Average Price (US$/Kg) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Psychobiotics, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Psychobiotics, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Psychobiotics, Product Type & Application
 Table 12. Global Key Manufacturers of Psychobiotics, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Psychobiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psychobiotics as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Psychobiotics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Psychobiotics Sales by Region (2019-2024) & (Ton)
 Table 18. Global Psychobiotics Sales Market Share by Region (2019-2024)
 Table 19. Global Psychobiotics Sales by Region (2025-2030) & (Ton)
 Table 20. Global Psychobiotics Sales Market Share by Region (2025-2030)
 Table 21. Global Psychobiotics Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Psychobiotics Revenue Market Share by Region (2019-2024)
 Table 23. Global Psychobiotics Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Psychobiotics Revenue Market Share by Region (2025-2030)
 Table 25. North America Psychobiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Psychobiotics Sales by Country (2019-2024) & (Ton)
 Table 27. North America Psychobiotics Sales by Country (2025-2030) & (Ton)
 Table 28. North America Psychobiotics Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Psychobiotics Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Psychobiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Psychobiotics Sales by Country (2019-2024) & (Ton)
 Table 32. Europe Psychobiotics Sales by Country (2025-2030) & (Ton)
 Table 33. Europe Psychobiotics Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Psychobiotics Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Psychobiotics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Psychobiotics Sales by Region (2019-2024) & (Ton)
 Table 37. Asia Pacific Psychobiotics Sales by Region (2025-2030) & (Ton)
 Table 38. Asia Pacific Psychobiotics Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Psychobiotics Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Psychobiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Psychobiotics Sales by Country (2019-2024) & (Ton)
 Table 42. Latin America Psychobiotics Sales by Country (2025-2030) & (Ton)
 Table 43. Latin America Psychobiotics Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Psychobiotics Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Psychobiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Psychobiotics Sales by Country (2019-2024) & (Ton)
 Table 47. Middle East and Africa Psychobiotics Sales by Country (2025-2030) & (Ton)
 Table 48. Middle East and Africa Psychobiotics Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Psychobiotics Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Psychobiotics Sales (Ton) by Type (2019-2024)
 Table 51. Global Psychobiotics Sales (Ton) by Type (2025-2030)
 Table 52. Global Psychobiotics Sales Market Share by Type (2019-2024)
 Table 53. Global Psychobiotics Sales Market Share by Type (2025-2030)
 Table 54. Global Psychobiotics Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Psychobiotics Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Psychobiotics Revenue Market Share by Type (2019-2024)
 Table 57. Global Psychobiotics Revenue Market Share by Type (2025-2030)
 Table 58. Global Psychobiotics Price (US$/Kg) by Type (2019-2024)
 Table 59. Global Psychobiotics Price (US$/Kg) by Type (2025-2030)
 Table 60. Global Psychobiotics Sales (Ton) by Application (2019-2024)
 Table 61. Global Psychobiotics Sales (Ton) by Application (2025-2030)
 Table 62. Global Psychobiotics Sales Market Share by Application (2019-2024)
 Table 63. Global Psychobiotics Sales Market Share by Application (2025-2030)
 Table 64. Global Psychobiotics Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Psychobiotics Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Psychobiotics Revenue Market Share by Application (2019-2024)
 Table 67. Global Psychobiotics Revenue Market Share by Application (2025-2030)
 Table 68. Global Psychobiotics Price (US$/Kg) by Application (2019-2024)
 Table 69. Global Psychobiotics Price (US$/Kg) by Application (2025-2030)
 Table 70. Lallemand Inc Company Information
 Table 71. Lallemand Inc Description and Business Overview
 Table 72. Lallemand Inc Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 73. Lallemand Inc Psychobiotics Product
 Table 74. Lallemand Inc Recent Developments/Updates
 Table 75. Novonesis (Novozymes A/S) Company Information
 Table 76. Novonesis (Novozymes A/S) Description and Business Overview
 Table 77. Novonesis (Novozymes A/S) Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 78. Novonesis (Novozymes A/S) Psychobiotics Product
 Table 79. Novonesis (Novozymes A/S) Recent Developments/Updates
 Table 80. Bened Biomedical Company Information
 Table 81. Bened Biomedical Description and Business Overview
 Table 82. Bened Biomedical Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 83. Bened Biomedical Psychobiotics Product
 Table 84. Bened Biomedical Recent Developments/Updates
 Table 85. Sabinsa Corporation Company Information
 Table 86. Sabinsa Corporation Description and Business Overview
 Table 87. Sabinsa Corporation Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 88. Sabinsa Corporation Psychobiotics Product
 Table 89. Sabinsa Corporation Recent Developments/Updates
 Table 90. DuPont Nutrition & Biosciences Company Information
 Table 91. DuPont Nutrition & Biosciences Description and Business Overview
 Table 92. DuPont Nutrition & Biosciences Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 93. DuPont Nutrition & Biosciences Psychobiotics Product
 Table 94. DuPont Nutrition & Biosciences Recent Developments/Updates
 Table 95. Kerry Group Company Information
 Table 96. Kerry Group Description and Business Overview
 Table 97. Kerry Group Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 98. Kerry Group Psychobiotics Product
 Table 99. Kerry Group Recent Developments/Updates
 Table 100. Bioprox Company Information
 Table 101. Bioprox Description and Business Overview
 Table 102. Bioprox Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 103. Bioprox Psychobiotics Product
 Table 104. Bioprox Recent Developments/Updates
 Table 105. Chr. Hansen Company Information
 Table 106. Chr. Hansen Description and Business Overview
 Table 107. Chr. Hansen Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 108. Chr. Hansen Psychobiotics Product
 Table 109. Chr. Hansen Recent Developments/Updates
 Table 110. Mystical Biotech Company Information
 Table 111. Mystical Biotech Description and Business Overview
 Table 112. Mystical Biotech Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 113. Mystical Biotech Psychobiotics Product
 Table 114. Mystical Biotech Recent Developments/Updates
 Table 115. Synbiotech Company Information
 Table 116. Synbiotech Description and Business Overview
 Table 117. Synbiotech Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 118. Synbiotech Psychobiotics Product
 Table 119. Synbiotech Recent Developments/Updates
 Table 120. Glac biotech Co., Ltd. Company Information
 Table 121. Glac biotech Co., Ltd. Description and Business Overview
 Table 122. Glac biotech Co., Ltd. Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 123. Glac biotech Co., Ltd. Psychobiotics Product
 Table 124. Glac biotech Co., Ltd. Recent Developments/Updates
 Table 125. Ildong Bioscience Co. Ltd Company Information
 Table 126. Ildong Bioscience Co. Ltd Description and Business Overview
 Table 127. Ildong Bioscience Co. Ltd Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 128. Ildong Bioscience Co. Ltd Psychobiotics Product
 Table 129. Ildong Bioscience Co. Ltd Recent Developments/Updates
 Table 130. JuneYao Health (BioGrowing Co., Ltd) Company Information
 Table 131. JuneYao Health (BioGrowing Co., Ltd) Description and Business Overview
 Table 132. JuneYao Health (BioGrowing Co., Ltd) Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 133. JuneYao Health (BioGrowing Co., Ltd) Psychobiotics Product
 Table 134. JuneYao Health (BioGrowing Co., Ltd) Recent Developments/Updates
 Table 135. Unique Biotech Company Information
 Table 136. Unique Biotech Description and Business Overview
 Table 137. Unique Biotech Psychobiotics Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 138. Unique Biotech Psychobiotics Product
 Table 139. Unique Biotech Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Psychobiotics Distributors List
 Table 143. Psychobiotics Customers List
 Table 144. Psychobiotics Market Trends
 Table 145. Psychobiotics Market Drivers
 Table 146. Psychobiotics Market Challenges
 Table 147. Psychobiotics Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Psychobiotics
 Figure 2. Global Psychobiotics Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Psychobiotics Market Share by Type: 2023 & 2030
 Figure 4. Bifidobacterium Longum Product Picture
 Figure 5. Lactobacillus Acidophilus Product Picture
 Figure 6. Lactobacillus Casei Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Psychobiotics Market Value by Application (2024-2030) & (US$ Million)
 Figure 9. Global Psychobiotics Market Share by Application: 2023 & 2030
 Figure 10. Depression
 Figure 11. Stress
 Figure 12. Anxiety
 Figure 13. Other
 Figure 14. Global Psychobiotics Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Psychobiotics Market Size (2019-2030) & (US$ Million)
 Figure 16. Global Psychobiotics Sales (2019-2030) & (Ton)
 Figure 17. Global Psychobiotics Average Price (US$/Kg) & (2019-2030)
 Figure 18. Psychobiotics Report Years Considered
 Figure 19. Psychobiotics Sales Share by Manufacturers in 2023
 Figure 20. Global Psychobiotics Revenue Share by Manufacturers in 2023
 Figure 21. Global 5 and 10 Largest Psychobiotics Players: Market Share by Revenue in Psychobiotics in 2023
 Figure 22. Psychobiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 23. Global Psychobiotics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 24. North America Psychobiotics Sales Market Share by Country (2019-2030)
 Figure 25. North America Psychobiotics Revenue Market Share by Country (2019-2030)
 Figure 26. United States Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Canada Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. Europe Psychobiotics Sales Market Share by Country (2019-2030)
 Figure 29. Europe Psychobiotics Revenue Market Share by Country (2019-2030)
 Figure 30. Germany Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. France Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. U.K. Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Italy Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Russia Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Asia Pacific Psychobiotics Sales Market Share by Region (2019-2030)
 Figure 36. Asia Pacific Psychobiotics Revenue Market Share by Region (2019-2030)
 Figure 37. China Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Japan Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. South Korea Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. India Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Australia Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. China Taiwan Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Southeast Asia Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Latin America Psychobiotics Sales Market Share by Country (2019-2030)
 Figure 45. Mexico Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Brazil Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Argentina Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Colombia Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Middle East and Africa Psychobiotics Sales Market Share by Country (2019-2030)
 Figure 50. Middle East and Africa Psychobiotics Revenue Market Share by Country (2019-2030)
 Figure 51. Turkey Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. UAE Psychobiotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Global Sales Market Share of Psychobiotics by Type (2019-2030)
 Figure 55. Global Revenue Market Share of Psychobiotics by Type (2019-2030)
 Figure 56. Global Psychobiotics Price (US$/Kg) by Type (2019-2030)
 Figure 57. Global Sales Market Share of Psychobiotics by Application (2019-2030)
 Figure 58. Global Revenue Market Share of Psychobiotics by Application (2019-2030)
 Figure 59. Global Psychobiotics Price (US$/Kg) by Application (2019-2030)
 Figure 60. Psychobiotics Value Chain
 Figure 61. Psychobiotics Production Process
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

High Sensitivity Information Solutions - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-2X14886
Sun Nov 24 00:00:00 UTC 2024

Add to Cart

Pets Antibiotic Treatment Solutions - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-13Q12777
Mon Nov 18 00:00:00 UTC 2024

Add to Cart

Nocturia Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-39M10215
Mon Nov 18 00:00:00 UTC 2024

Add to Cart

Medicine Treat BPH - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-33F12613
Mon Nov 18 00:00:00 UTC 2024

Add to Cart